Michael J. Pishvaian, Edik Matthew Blais, Lynn M. Matrisian, Jonathan R Brody, Dzung Thach, Patricia Miren de Arbeloa, Flavio G. Rocha, Jennifer W. Chuy, Raymond Couric Wadlow, Andrew Eugene Hendifar, Emanuel Petricoin. "Validation of PDACai v2.0 in predicting relative benefit from frontline FOLFIRINOX (FFX) and gemcitabine/nab-paclitaxel (GA) for patients (pts) with metastatic pancreatic cancer (mPDAC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.776